Combination therapy for the prevention and treatment of osteopor

Details Combination therapy for the prevention and treatment of osteopor Combination therapy for the prevention and treatment of osteopor

1998-05-01

2000-03-28

Leary, Louise N.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

435 6, 424520, 424 145, 424 91, 530399, 552502, C12Q 100, A61K 5100

Patent

active

060430265

ABSTRACT:
The combination of an estrogen receptor modulator and a growth hormone secretagogue is useful in the treatment or prevention of diseases involving bone resorption, especially osteoporosis.

REFERENCES:
patent: 5118667 (1992-06-01), Adams et al.
patent: 5457117 (1995-10-01), Black et al.
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5494929 (1996-02-01), Grese
patent: 5534527 (1996-07-01), Black et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5550134 (1996-08-01), Audia et al.
patent: 5767124 (1998-06-01), Draper et al.

Affiliated with

Also associated with

Rating

Combination therapy for the prevention and treatment of osteopor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for the prevention and treatment of osteopor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for the prevention and treatment of osteopor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1324936